PIERIS PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pieris Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2023.
  • Pieris Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $0.000, a 100% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $0 -$3.4M -100% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.82M +$199K +5.5% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.8M -$48K -1.25% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.71M -$204K -5.22% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $3.4M -$575K -14.5% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $3.62M -$244K -6.32% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $3.84M +$55K +1.45% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $3.91M -$25K -0.64% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $3.97M +$296K +8.05% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $3.86M +$587K +17.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $3.79M +$619K +19.5% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $3.93M +$498K +14.5% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $3.68M Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $3.27M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.17M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $3.44M +$3.44M Dec 31, 2019 10-K 2021-03-31
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.